Close
Help




JOURNAL

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

137,438 Journal Article Views | Journal Analytics

Pharmacotherapies for COPD

Submit a Paper



Publication Date: 25 Apr 2013

Type: Review

Journal: Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

Citation: Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 2013:7 17-34

doi: 10.4137/CCRPM.S7211

Abstract

This review article summarizes the main treatments for chronic obstructive pulmonary disease, their mechanisms, and the key evidence from trials supporting their use. Drug classes covered were short acting beta agonists (SABA), short acting muscarinic antagonists (SAMA), long acting beta agonists (LABA), long acting antimuscarinics (LAMA), inhaled corticosteroids (ICS), LABA/ICS combinations, specific phosphodiesterase (PDE4) inhibitors, non-specific PDE inhibitors, mucolytics, and oxygen. Non-specific therapies, such as opiates for relief of dyspnoea and therapies for smoking cessation, are also covered briefly. For each class of drug, mechanisms of action are described, key clinical trial results are reported, and available agents compared. Finally, the place of each drug in therapy is compared between current worldwide guidelines.


Downloads

PDF  (700.86 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML






What Your Colleagues Say About Libertas Academica
In my opinion the review process in all the Libertas Academica journals I have had the privilege of reviewing papers for is second to none.  The entire process is a click away and all the editorial staff are very cooperative.  The papers that are submitted are of top quality and I am sure the journals will gain the status of high impact journals in a very short time.
Dr C. Shekhar Mayanil (Children's Memorial Research Center, Chicago, IL, USA)
More Testimonials

Quick Links


New article and journal news notification services